Compare AbbVie Inc (ABBV) vs Reddit Inc (RDDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbbVie Inc vs Reddit Inc — how do they compare? AbbVie Inc trades at $249.74 (market cap $441.94B), while Reddit Inc trades at $153.2 (market cap $30.05B). The key difference: AbbVie Inc is far larger — about 14.7× Reddit Inc's market cap, and AbbVie Inc pays a 2.77% dividend while Reddit Inc pays none. Which is the better fit depends on your goals.
| ABBV | RDDT | |
|---|---|---|
Market Cap | $441.94B | $30.05B |
Sector | Health | Media |
52-Week High | $263.58 | $270.71 |
52-Week Low | $197.38 | $121.84 |
Enterprise Value | $506.19B | $27.28B |
Dividend Yield | 2.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $247.91, up 0.76% today, with a bullish technical signal and strong analyst support. Recent earnings beats and a 70.73% buy consensus highlight robust fundamentals, driven by Skyrizi and Rinvoq growth offsetting Humira declines. Positive news includes Phase 2 ovarian cancer data and institutional stake increases, reinforcing momentum.
Outlook remains positive with a $278.69 price target, though risks include patent cliffs and debt levels. Revenue growth and dividend stability offer appeal, but investors should monitor competitive pressures and regulatory developments for sustained performance.
Reddit (RDDT) trades at $152.50, down 3.91% amid a bearish technical signal despite strong Q2 2026 results showing 61% revenue growth and earnings beats. The stock faces selling pressure despite analyst consensus of $220.25 price target and 64% buy ratings. Recent CEO share sales and search traffic concerns have weighed on sentiment, though fundamentals remain robust with 31.35% net margins and positive cash flow trends.
The outlook remains bifurcated with strong fundamental performance contrasting with technical weakness. Investment opportunity lies in discounted valuation post-selloff and AI monetization potential, while risks include user growth sustainability and competitive pressures in social media landscape. The stock presents a growth-at-reasonable-price case if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →
